Skip to main content
. 2022 Oct 24;96(6):620–630. doi: 10.1159/000527653

Fig. 1.

Fig. 1

PRISMA diagram of the study selection process. *Given the scarcity of data on SGLT2 inhibitor use in youth with type 1 diabetes, no strict exclusion criteria were used. SGLT2, sodium-glucose co-transporter-2.